BioHarvest Sciences Inc.BHST
Key ratios
FCF / Sales
-27.8%2025
2024
-37.8%2023
-78.9%
Net margin
-31.2%TTM
2025
-32.3%2024
-51.3%2023
-99.2%
ROA
-9.6%2025
2024
-21.8%2023
-51.1%
ROE
-142.5%TTM
2025
-83.2%
Revenue growth
17.5%TTM
2025
37.0%2024
98.8%2023
130.5%
Recent news
BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product
BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update
BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance
Track BHST in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer